Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies

• Váldodahkkit: Ashleigh Hooimeyer (Dahkki), Alice Bhasale (Dahkki), Lucy Perry (Dahkki), Alice Fabbri (Dahkki), Annim Mohammad (Dahkki), Eliza McEwin (Dahkki), Barbara Mintzes (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2020-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Information on rare adverse effects is often limited when a medication is initially approved for marketing. Medicines regulators use safety advisories to warn health professionals and consumers about emerging harms. This study aimed to identify characteristics and advice provided in cardiac...